A natural history of melanomas and dysplastic nevi: An atlas of lesions in melanoma-prone families

Cancer

Volumn 94, Issue 12, 2002, Pages 3192-3209

  Tucker, Margaret A ^a   Fraser, Mary C ^a   Goldstein, Alisa M ^a   Struewing, Jeffery P ^a   King, Mary A ^b   Crawford, John T ^b   Chiazze, Ellen A ^c   Zametkin, Deborah P ^c   Fontaine, Laura S ^c   Clark Jr , Wallace H ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c WESTAT   (United States)

^d NONE

Author keywords

Dysplastic nevi; Familial melanoma; Genetics; Melanoma

Indexed keywords

ADULT; ARTICLE; CANCER GENETICS; CANCER RISK; CARCINOGENESIS; CLINICAL FEATURE; DYSPLASTIC NEVUS; GENE MUTATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL;

CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DYSPLASTIC NEVUS SYNDROME; GENES, P16; HUMANS; MELANOMA; MUTATION; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; SELF-EXAMINATION; SKIN NEOPLASMS;

EID: 0037096962     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10605     Document Type: Article

References (45)

1. Genotype-phenotype relationships in American melanoma-prone families with CDKN2A and CDK4 mutations
2. Origin of familial malignant melanomas from heritable melanocytic lesions: The B-K mole syndrome
3. Familial atypical multiple mole-melanoma syndrome
4. Acquired precursors of cutaneous malignant melanoma: The familial dysplastic nevus syndrome
5. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi
6. Consensus on the management of malignant melanoma of the skin in the Netherlands
7. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma
8. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups
9. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
10. Model predicting survival in stage I melanoma based on tumor progression
11. The early and intermediate precursor lesions of tumor progression in the melanocytic system: Common acquired nevi and atypical (dysplastic) nevi
12. Problems with lesions related to the development of malignant melanoma: Common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma
13. Histopathologic diagnosis of dysplastic nevi: Concordance among pathologists convened by the World Health Organization Melanoma Programme
14. Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group
15. The risk of melanoma and other cancers in melanoma-prone families
16. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity
17. Editorial: Screening for CDKN2A mutations in hereditary melanoma
18. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
19. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France
20. Counselling and DNA testing for individuals perceived to be genetically predisposed to melanoma. A consensus statement of the Melanoma Genetics Consortium
21. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations
22. Cutaneous malignant melanoma and familial dysplastic nevi: Evidence for autosomal dominance and pleiotropy
23. Genecovariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families
24. Number of melanocytic nevi as a major risk factor for malignant melanoma
25. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma
26. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma: A casecontrol study
27. Natural history of dysplastic nevi
28. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?
29. Melanoma risk in individuals with clinically atypical nevi
30. Risk of cutaneous malignant melanoma in patients with 'classic' atypical mole syndrome: A case-control study
31. Risk factors for melanoma incidence in prospective follow-up: The importance of atypical (dysplastic) nevi
32. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: Multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society
33. Clinically recognized dysplastic nevi: A central risk factor for cutaneous melanoma
34. Prevalence of dysplastic naevi in a community practice
35. Dysplastic naevi in a population-based survey
36. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
37. INK4 mutations
38. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance
39. Sun-related risk factors in melanoma-prone families with CDKN2A mutations
40. Melanoma and sun exposure: Where are we now?
41. Melanoma development in relation to non-functional p16/INK4A protein and dysplastic naevus syndrome in Swedish melanoma kindreds
42. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma
43. The Dutch FAMMM family material: Clinical and genetic data
44. Clinical characteristics of 20 Italian melanoma-prone families
45. Characteristics of familial and non-familial melanoma in Australia